Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
Presbyopia, the age-related loss of near vision, could soon be treated successfully
Fresh Phase 1b/2a data highlight the strength of the iberdomide + daratumumab + dexamethasone combination in transplant-deferred or ineligible NDMM
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
Subscribe To Our Newsletter & Stay Updated
